AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
261.72
+1.73 (0.67%)
At close: Sep 2, 2026, 4:00 PM EDT
261.80
+0.08 (0.03%)
After-hours: Sep 2, 2026, 7:59 PM EDT
AbbVie Employees
AbbVie had 57,000 employees as of December 31, 2025. The number of employees increased by 2,000 or 3.64% compared to the previous year.
Employees
57,000
Change (1Y)
2,000
Growth (1Y)
3.64%
Revenue / Employee
$1,129,579
Profits / Employee
$110,000
Market Cap
462.49B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57,000 | 2,000 | 3.64% |
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | 0 | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| AstraZeneca | 95,100 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| Novo Nordisk | 69,505 |
| Eli Lilly and Company | 50,000 |
ABBV News
- 1 day ago - AbbVie’s Allergan expands SkinMedica’s portfolio with Barrier Calming Cream - TheFly
- 1 day ago - SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings - PRNewsWire
- 2 days ago - AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference - PRNewsWire
- 6 days ago - AbbVie submits Skyrizi application to the EMA - TheFly
- 6 days ago - AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease - PRNewsWire
- 12 days ago - AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline - PRNewsWire
- 13 days ago - AbbVie price target raised to $303 from $298 at Piper Sandler - TheFly
- 15 days ago - AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support - PRNewsWire